课题基金 / 基金详情

A new generation of Crystallographic detector for Multi-user Barkla X-ray laboratory

A new generation of Crystallographic detector for Multi-user Barkla X-ray laboratory
适用于多用户 Barkla X 射线实验室的新一代晶体探测器
批准号:
BB/R000220/1
负责人:
Svetlana Antonyuk
金额:
$27.98万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
X-ray crystallography offers the opportunity to observe highest level of details in protein and RNA/DNA molecules. It has delivered unrivalled knowledge of many biological processes including respiration, photosynthesis, cell signalling, receptor's activation and enzymatic mechanisms. The way we think of biology and biological processes has transformed due to our ability to determine high-resolution structures of even the most complex systems. It also has revolutionized modern drug discovery and structure-based drug/lead-compounds have become a commonplace. The tremendous success of X-ray crystallography over the last 30 years has largely been due to the availability of highly intense Synchrotron Radiation (SR) facilities. During the last couple of decades, the SR sources have seen tremendous progress in the performance in terms of brightness where the brightness gain has been twice as fast as the rate of improvement in semiconductors (Moore's law), The increasing X-ray photon density delivered by the increasingly brighter sources has required rapid development in beamlines, optical elements and detectors. A major improvement in detectors from photographic plates to image plate to Charged Coupled Detectors (CCDs) emerged at the end of last century. DIAMOND Synchrotron opened its operation with MX beamlines using large CCDs but all of these have been replaced by photon counting hybrid pixel array silicon detectors (HPC) - in fact DIAMOND set the pace of change capitalizing on the development of HPC detectors that originated at the Swiss Light Source. The laboratory sources have continued three important roles, namely (i) pre-screening of crystals, their initial characterisation and establishment of soaking conditions of ligands/compounds/inhibitors, (ii) determination of structures of well diffracting systems (in fact the number of structures determined using laboratory sources per annum currently is the same as in the 1980s/90s) and (iii) train and equip PhD students and PDRA with in-depth skills not just in the use (as a user) but acquire in-depth understanding of instrumentation as well as the subtleties of data collection. The laboratory sources (and associated optics) have also improved and detector technology is also advancing but a decade or so behind the synchrotron. Only recently the technology of photon counting hybrid pixel array silicon detectors has become available for laboratory sources at a fraction of the price compared to detectors that are being bought for synchrotrons. This reduction in price has been achieved by matching the specifications of these new generations of HPC detectors to the laboratory sources. X-ray detectors must collect, quantize and digitize incoming X-rays while preserving highly precise location information. State-of-the-art new generation HPC X-ray detectors can collect X-rays with exceptional (>99 %) quantum efficiency. In recent years reduction of pixel size has increased the quality of the data collected; similar to increasing screen resolution in high definition televisions. Dectris have led the way in hybrid pixel array detectors and their new EIGER range combine small pixel size with high quantum efficiency and signal to noise. The EIGER R range is tailored for more intense laboratory sources and is capable of high-count rates with continuous readout and have small (75 microns) pixels, similar to our current MAR225CCD, which is now 12 years old. The provision of this latest generation of detector will not only ensure continued successful operation of the Barkla laboratory but also will enhance our capabilities for weekly diffracting systems including membrane protein crystals and multi-component complexes.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1107/s2052252517016128
发表时间: 2018-01-01
期刊: IUCrJ
影响因子: 3.9
作者: [Halsted TP, Yamashita K, Hirata K, Ago H, Ueno G, Tosha T, Eady RR, Antonyuk SV, Yamamoto M, Hasnain SS]
通讯作者: Hasnain SS
DOI: 10.1107/s2052252518008242
发表时间: 2018-07-01
期刊: IUCrJ
影响因子: 3.9
作者: [Dong J, Sasaki D, Eady RR, Antonyuk SV, Hasnain SS]
通讯作者: Hasnain SS
DOI: 10.1093/hmg/ddx133
发表时间: 2017-07-01
期刊: Human molecular genetics
影响因子: 3.5
作者: [Helassa N, Antonyuk SV, Lian LY, Haynes LP, Burgoyne RD]
通讯作者: Burgoyne RD
DOI: 10.1039/d0sc04797j
发表时间: 2020-10-20
期刊: Chemical science
影响因子: 8.4
作者: [Hough MA, Conradie J, Strange RW, Antonyuk SV, Eady RR, Ghosh A, Hasnain SS]
通讯作者: Hasnain SS
国内基金
海外基金
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
  • 批准号:
    82371660
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    魏喆
  • 依托单位:
Next Generation Majorana Nanowire Hybrids
二次谐波非线性光学显微成像用于前列腺癌的诊断及药物疗效初探
  • 批准号:
    30470495
  • 项目类别:
    面上项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2004
  • 负责人:
    邓小元
  • 依托单位: